C2orf30 anticorps (Middle Region)
Aperçu rapide pour C2orf30 anticorps (Middle Region) (ABIN632582)
Antigène
Voir toutes C2orf30 (ERLEC1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- C2 orf30 antibody was raised against the middle region of C2 rf30
-
Purification
- Affinity purified
-
Immunogène
- C2 orf30 antibody was raised using the middle region of C2 rf30 corresponding to a region with amino acids GKHVHQYHEDKDSGKTSVVVGTWNQEEHIEWAKKNTARAYHLQDDGTQTV
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
C2orf30 Blocking Peptide, (ABIN938749), is also available for use as a blocking control in assays to test for specificity of this C2orf30 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of C0 rf30 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- C2orf30 (ERLEC1) (Endoplasmic Reticulum Lectin 1 (ERLEC1))
-
Autre désignation
- C2orf30
-
Sujet
- C2orf30 is a probable lectin that binds selectively to improperly folded lumenal proteins. May function in endoplasmic reticulum quality control and endoplasmic reticulum-associated degradation (ERAD) of both non-glycosylated proteins and glycoproteins.
-
Poids moléculaire
- 55 kDa (MW of target protein)
-
Pathways
- SARS-CoV-2 Protein Interactome
Antigène
-